4basebio (LON:4BB) Insider Amy Walker Purchases 2,650 Shares

4basebio PLC (LON:4BB) insider Amy Walker acquired 2,650 shares of 4basebio stock in a transaction on Friday, February 13th. The shares were bought at an average cost of GBX 586 per share, with a total value of £15,529.

4basebio Trading Down 0.1%

Shares of 4BB stock opened at GBX 569.20 on Tuesday. The company has a market capitalization of £88.14 million, a P/E ratio of -5.75 and a beta of 1.09. The company has a current ratio of 2.73, a quick ratio of 3.52 and a debt-to-equity ratio of 201.47. The business’s 50 day moving average is GBX 597.71 and its two-hundred day moving average is GBX 727.91. 4basebio PLC has a twelve month low of GBX 520 and a twelve month high of GBX 1,220.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.